4D Molecular Therapeutics reports positive interim data for 4D-150 in wet AMD and DME, with strong financial ... product candidates for the therapeutic uses for which they are being studied.
aflibercept, according to study data. Patients with DME and neovascular AMD who were treated with faricimab demonstrated noninferior vision gains and improved anatomical outcomes vs. those treated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback